Document Detail


Glutamate Metabolism in Major Depressive Disorder.
MedLine Citation:
PMID:  25073688     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: Emerging evidence suggests that abnormalities in amino acid neurotransmitter function and impaired energy metabolism contribute to the underlying pathophysiology of major depressive disorder. To test whether impairments in energetics and glutamate neurotransmitter cycling are present in major depression, we used carbon-13 magnetic resonance spectroscopy (13C MRS) to measure these fluxes in individuals diagnosed with major depression relative to healthy comparison subjects.
Method: Proton (1H) MRS and 13C MRS data were collected for 23 medication-free individuals with major depression and 17 healthy subjects. 1H MRS provided total glutamate and GABA concentrations, and 13C MRS, coupled with intravenous infusion of [1-13C]glucose, provided measures of the neuronal tricarboxylic acid cycle for mitochondrial energy production, GABA synthesis, and glutamate/glutamine cycling from voxels situated in the occipital cortex.
Results: Mitochondrial energy production of glutamatergic neurons was 26% lower in the depression group. Paradoxically, no difference was found in the rate of the glutamate/glutamine cycle (Vcycle). A significant correlation was observed between glutamate concentrations and Vcycle in the overall sample.
Conclusions: The authors interpret the reduction in mitochondrial energy production as being due to either mitochondrial dysfunction or a reduction in proper neuronal input or synaptic strength. Future MRS studies could help distinguish these possibilities.
Authors:
Chadi G Abdallah; Lihong Jiang; Henk M De Feyter; Madonna Fasula; John H Krystal; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Related Documents :
21899708 - No effect of perianal application of topical anaesthetic on patient comfort during non-...
22397888 - Undiagnosed bipolar disorder in patients treated for major depression in china.
23209928 - Assessment of the efficacy and safety of a new treatment for head lice.
21727148 - Oral fingolimod (fty720) in relapsing multiple sclerosis: impact on health-related qual...
3236018 - Parkinson's disease and depression: psychometric properties of the beck depression inve...
19889358 - Quality of life of patients with oral and pharyngeal malignancies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-30
Journal Detail:
Title:  The American journal of psychiatry     Volume:  -     ISSN:  1535-7228     ISO Abbreviation:  Am J Psychiatry     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-7-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370512     Medline TA:  Am J Psychiatry     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functionalized Graphitic Carbon Nitride for Metal-free, Flexible and Rewritable Nonvolatile Memory D...
Next Document:  Epilepsy, Cognition and Behavior.